Breathe BioMedical Inc. (BRTH)

Breathe BioMedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.51	1.64	0.55	-
Short-Term Investments	0.03	0.03	0.03	-
Cash & Cash Equivalents	2.53	1.66	0.57	0
Cash Growth	-	190.56%	-	-
Receivables	-	0.87	0.94	-
Other Current Assets	-	0.04	0.04	-
Total Current Assets	-	2.57	1.55	-
Property, Plant & Equipment	-	1.57	1.82	-
Goodwill and Intangibles	-	0.61	-	-
Total Long-Term Assets	-	2.18	1.82	-
Total Assets	-	4.75	3.37	-
Accounts Payable	-	1.77	1.38	-
Current Debt	-	0.33	0.16	-
Total Current Liabilities	-	2.1	1.53	-
Long-Term Debt	-	1.6	1.07	-
Total Long-Term Liabilities	-	1.6	1.07	-
Total Liabilities	-	3.7	2.61	-
Total Debt	3.31	1.93	1.23	-
Debt Growth	-	56.77%	-	-
Retained Earnings	-	-23.8	-15.44	-
Shareholders' Equity	0.17	1.05	0.46	-
Net Cash / Debt	-0.78	-0.27	-0.66	0
Working Capital	-	0.47	0.01	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).